Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm’s products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
You May Also Like
Owners of French bulldogs worry about breeds’ rising popularity
Owners of French bulldogs worry about breeds’ rising popularity – CBS News…
- ReportWire
- March 18, 2023
Ask Amy: Jokes about suicide bother me
Dear Amy: My little sister died almost two years ago by suicide…
- ReportWire
- December 11, 2022
APPS Stock Price | Digital Turbine Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Digital Turbine Inc. Digital Turbine, Inc. engages in the innovation of media…
- ReportWire
- November 13, 2023
Ron Howard admits he considered directing porn for directorial debut
Ron Howard found fame in front of the camera at an early…
- ReportWire
- April 3, 2023